Table 1.
Demographics of patients at respiratory assessment centre by initial visit type.
| Demographics | Initial telehealth visit (n = 564) | Initial office visit (n = 741) | P-valuea |
|---|---|---|---|
| Age | Median 43.47 (mean 42.7) | Median 42.05 (mean 40.1) | 0.023 |
| Female % | 66.8 | 63.6 | 0.218 |
| Comorbidity | |||
| Hypertension | 148 (26.2%) | 200 (27.0%) | 0.762 |
| Diabetes | 69 (12.2%) | 83 (11.2%) | 0.564 |
| Obesityb | 252 (44.7%) | 295 (39.8%) | 0.077 |
| Chronic obstructive pulmonary disease | 26 (4.6%) | 36 (4.9%) | 0.834 |
| Asthma | 101 (17.9%) | 104 (14.0%) | 0.057 |
| Obstructive sleep apnoea | 66 (11.7%) | 67 (9.0%) | 0.116 |
| CAD/heart failure | 40 (7.1) | 45 (6.1%) | 0.460 |
| HIV | 2 (0.4%) | 8 (1.1%) | 0.137 |
| Chronic kidney disease | 7 (1.2%) | 20 (2.7%) | 0.067 |
| Immunosuppressivesc | 26 (4.6%) | 33 (4.5%) | 0.893 |
| Smokingd | 110 (19.5%) | 98 (13.2%) | 0.002 |
|
Mean comorbidities (SD) |
Mean comorbidities (SD) |
||
| 1.50 (1.45) | 1.33 (1.44) | 0.039 |
aChi-square for individual comorbidities, independent t-test for total comorbidities and age.
bDefined as body mass index (BMI) ≥30.
cIncluded patients on biologic immunosuppression or long-term steroid therapy based on medication list.
dOnly included current smokers of any duration.
CAD: coronary heart disease; HIV: human immunodeficiency virus.